Rodrigo, Adrian - Search Results - UAB Digital Repository of Documents

Search collections:

Sort by:	Display results:	Output format:

Results overview: Found 2 records in 0.02 seconds.
Articles, 2 records found

Articles	2 records found

9 p, 227.9 KB

Complementary pre-screening strategies to uncover hidden prodromal and mild Alzheimer's disease : Results from the MOPEAD project / Boada, Mercè (Universitat Internacional de Catalunya) ; Rodrigo, Adrián (GMV SECURE E SOLUTIONS) ; Jessen, Frank (Faculty of Medicine and University Hospital Cologne) ; Wimblad, Bengt (Karolinska Univ Hospital) ; Kramberger, Milica G. (Univerza V Ljubljani) ; Visser, Pieter Jelle (Maastricht University) ; Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron) ; Rodríguez-Gomez, Octavio (Universitat Internacional de Catalunya) ; Ciudin, Andreea (Hospital Universitari Vall d'Hebron) ; Georges, Jean (Alzheimer Europe) ; Dumas, Annete (ASDM Consulting) ; Maguire, Peggy (European Institute of Women's Health) ; Krivec, David (Zdruzenje Spomincica) ; Wimo, Anders (Karolinska Institutet (Estocolm, Suècia)) ; Valero, Sergi (Instituto de Salud Carlos III) ; Alegret, Montserrat (Instituto de Salud Carlos III) ; Jamilis, Laura (GMV SECURE E SOLUTIONS) ; Zwan, Marissa (Vrije Universiteit Amsterdam) ; Sannemann, Lena (Faculty of Medicine and University Hospital Cologne) ; Arrufat, Jordi (EAP Sarrià-Vallvidrera-Les Planes) ; Stomrud, Erik (Region Kalmar County) ; Johansson, Gunilla (Karolinska Institutet (Estocolm, Suècia)) ; Glaysher, Bridget (Modus Research and Innovation Limited) ; Stewart, Neil (Modus Research and Innovation Limited) ; Belger, Mark (Eli Lilly and Company (Lilly UK)) ; Iradier, Fatima (Eli Lilly and Company) ; Campo, Laura (Eli Lilly and Company) ; Universitat Autònoma de Barcelona
The Models of Patient Engagement for Alzheimer's Disease (MOPEAD) project was conceived to explore innovative complementary strategies to uncover hidden prodromal and mild Alzheimer's disease (AD) dementia cases and to raise awareness both in the general public and among health professionals about the importance of early diagnosis. [...]
2021 - DOI (Digital Object Identifier)

10.1002/alz.12441
Alzheimer's & Dementia, Vol. 18 (july 2021) , p. 1119-1127

Detailed record -

10 p, 661.4 KB

Clinical Applicability of the Specific Risk Score of Dementia in Type 2 Diabetes in the Identification of Patients with Early Cognitive Impairment : results of the MOPEAD Study in Spain / Ortiz-Zúñiga, Ángel Michael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rodriguez-Gómez, Octavio (Institut Català de Neurociènces Aplicades) ; Hernández, Cristina (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Rodrigo, Adrian (GMV Soluciones Globales Internet SAU. Valencia) ; Jamilis, Laura (GMV Soluciones Globales Internet SAU. Valencia) ; Campo, Laura (International Corporate Affairs, Alzheimer's Disease, Eli Lilly and Co. Italy) ; Alegret, Montserrat (Universitat Internacional de Catalunya. Institut Català de Neurociènces Aplicades) ; Boada, Mercè (Institut Català de Neurociènces Aplicades) ; Ciudin, Andreea (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Introduction: Although the Diabetes Specific Dementia Risk Score (DSDRS) was proposed for predicting risk of dementia at 10 years, its usefulness as a screening tool is unknown. For this purpose, the European consortium MOPEAD included the DSDRS within the specific strategy for screening of cognitive impairment in type 2 diabetes (T2D) patients attended in a third-level hospital. [...]
2020 - DOI (Digital Object Identifier)

10.3390/jcm9092726
Journal of clinical medicine, Vol. 9 Núm. 9 (2020) , p. 2726

Detailed record -

See also: similar author names
1	Rodrigo, A.
2	Rodrigo, Adrián
1	Rodrigo, Ana

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.